Abstract
Purpose
The objective of the present study is to analyze long-term testicular cancer (TC) survivors focusing on the correlation of therapeutic modalities used, the age of patients and second malignancy (SM) occurrence.
Patients and methods
A total of 1,367 patients with TC and different subsequent therapeutic procedures were followed up between 1970 and 2012. The occurrence of SM was analyzed by standard incidence ratios (SIR). SM occurred in 96 (7.0 %) patients with primary TC.
Results
The most frequent SM was TC (SIR 27.4, n = 64); a significantly higher occurrence was observed after primary testicular seminoma. Prostate cancer appeared in 10 patients (SIR 5.2), with a mean age 54.9 years, while the typical age of patients in Slovakia was 71.4 years. Kidney cancer developed in 6 patients, a significant higher SIR was registered only after primary non-seminomas. The mean patient’s age was 48.5 years, while the typical age of all male patients in Slovakia was 62.4 years. Other SM had no significantly higher SIR. Colorectal cancer appeared in 8 patients with primary TC, with a mean age 56.0 years, while the typical age of male patients with primary colorectal cancer in Slovakia was 67.1 years. Other non-testicular tumors appeared in 8 patients. SM occurs in 1.5 % of patients following orchiectomy alone, in 4.3 % following radiotherapy, 5.0 % following chemotherapy and in 4.4 % following combined chemo-radiotherapy.
Conclusions
Preliminary analyses indicate increased SM occurrence in patients with primary TC in comparison with the general population, and it also occurs in younger age at the time of SM diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ondrusova M, Plesko I, Safaei-Diba C, Obsitnikova A, Stefanakova D, Ondrus D (2007) Comprehensive analysis of incidence and mortality of malignant tumours in the Slovak Republic [online]. NCR SR, NHIC, Bratislava. http://www.nor-sk.org/
Safaei-Diba C, Plesko I, Frindtova V, Kopecka I, Krakovska B et al (2008) Cancer incidence in the Slovak Republic 2004. NCR SR, NHIC, Bratislava
Safaei-Diba C, Plesko I, Obsitnikova A, Dienerova M, Kalmancokova A et al (2009) Cancer incidence in the Slovak Republic 2005. NCR SR, NHIC, Bratislava
Safaei-Diba C, Plesko I, Hlava P (eds) (2010) Cancer incidence in the Slovak Republic 2006. NCR SR, NHIC, Bratislava
Safaei-Diba C, Plesko I, Hlava P (eds) (2012) Cancer incidence in the Slovak Republic 2007. NCR SR, NHIC, Bratislava
National Cancer Institute: Surveillance Research. Cancer Control and Population Sciences (2013) http://surveillance.cancer.gov/joinpoint/
Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for join point regression with applications to cancer rates. Stat Med 19:335–351
Hemminki K, Liu H, Sundquist J (2010) Second cancers after testicular cancer diagnosed after 1980 in Sweden. Ann Oncol 21:1546–1551
Zwahlen DR, Martin JM, Millar JL, Schneider U (2008) Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma. Int J Radiat Oncol Biol Phys 70:853–858
Lawrentschuk N, Gyomber D, Bolton DM (2006) Renal cell carcinoma following testicular cancer: case report and literature review. Int Urol Nephrol 38:1–4
Richiardi L, Scélo G, Boffetta P, Hemminki K, Pukkala E et al (2007) Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries. Int J Cancer 120:623–631
Travis LB, Fosså SD, Schonfeld SJ, Mc Master ML, Lynch CF et al (2005) Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Nat Cancer Inst 97:1354–1365
Tseng TS, Lin HY, Moody-Thomas S, Martin M, Chen T (2012) Who tended to continue smoking after cancer diagnosis: the National Health and Nutrition Examination Survey 1999–2008. BMC Public Health 12(784):1–9
Robinson D, Møller H, Horwich A (2007) Mortality and incidence of second cancers following treatment for testicular cancer. Br J Cancer 96:529–533
Büchler T, Kubankova P, Boublikova L, Donatova Z, Foldyna M et al (2011) Detection of second malignancies during long-term follow-up of testicular cancer survivors. Cancer 117:4212–4218
Simone CB, Kramer K, O’Meara WP, Bekelman JE, Belard A et al (2012) Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma. Int J Radiat Oncol Biol Phys 82:242–249
Schairer C, Hisada M, Chen BE, Brown LM, Fosså SD et al (2007) Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers. J Nat Cancer Inst 99:1248–1256
Haugnes HS, Bosl GJ, Boer H, Gietema JA, Brydøy M et al (2012) Long-term and late effects of germ cell testicular cancer treatment and implication for follow-up. J Clin Oncol 30:3752–3763
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2000) Some antiviral and antineoplastic drugs, and other pharmaceutical agents, IARC Monographs on the evaluation of carcinogenic risks to humans. IARC Press, Lyon
Van Leeuwen FE, Stiggelbout AM, Van den Belt-Dusebout AW, Noyon R, Eliel MR et al (1993) Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. J Clin Oncol 11:415–424
Van Walraven C, Fergusson D, Earle C, Baxter N, Alibhai S et al (2011) Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer. J Clin Oncol 29:2883–2888
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ondrus, D., Ondrusova, M. & Friedova, L. Second malignancies in long-term testicular cancer survivors. Int Urol Nephrol 46, 749–756 (2014). https://doi.org/10.1007/s11255-013-0554-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-013-0554-4